Cambridge Advisors Inc. Merck & Co., Inc. Transaction History

Cambridge Advisors Inc.

$416 Million
Q1 2024

A detailed history of Cambridge Advisors Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cambridge Advisors Inc. holds 11,416 shares of MRK stock, worth $1.41 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

11,416

Previous 10,892 4.81%

Holding current value

$1.41 Million

Previous $1.19 Million 26.87%

% of portfolio

0.36%

Previous 0.3%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$113.24 - $131.95 $59,337 - $69,141	524 Added 4.81%	11,416 $1.51 Million
Q4 2023 Jan 16, 2024	BUY	$100.18 - $109.02 $1,001 - $1,090	10 Added 0.09%	10,892 $1.19 Million
Q3 2023 Oct 18, 2023	SELL	$102.95 - $114.33 $91,728 - $101,868	-891 Reduced 7.57%	10,882 $1.12 Million
Q2 2023 Jul 13, 2023	SELL	$108.61 - $118.38 $240,679 - $262,330	-2,216 Reduced 15.84%	11,773 $1.36 Million
Q1 2023 Apr 13, 2023	BUY	$102.94 - $114.86 $15,441 - $17,229	150 Added 1.08%	13,989 $1.49 Million

Q4 2022 Jan 23, 2023	SELL	$87.44 - $112.11 $437 - $560	-5 Reduced 0.04%	13,839 $0
Q3 2022 Oct 17, 2022	SELL	$84.53 - $94.96 $32,966 - $37,034	-390 Reduced 2.74%	13,844 $1.19 Million
Q2 2022 Jul 18, 2022	SELL	$83.49 - $94.64 $45,919 - $52,052	-550 Reduced 3.72%	14,234 $1.3 Million
Q1 2022 May 05, 2022	BUY	$73.51 - $82.4 $808 - $906	11 Added 0.07%	14,784 $1.21 Million
Q4 2021 Jan 14, 2022	BUY	$72.28 - $90.54 $20,455 - $25,622	283 Added 1.95%	14,773 $1.13 Million
Q3 2021 Oct 19, 2021	BUY	$71.68 - $78.83 $788 - $867	11 Added 0.08%	14,490 $1.09 Million
Q2 2021 Jul 21, 2021	SELL	$70.31 - $77.77 $5,554 - $6,143	-79 Reduced 0.54%	14,479 $1.13 Million
Q1 2021 Apr 22, 2021	BUY	$68.86 - $81.11 $688 - $811	10 Added 0.07%	14,558 $1.12 Million
Q4 2020 Jan 25, 2021	BUY	$71.77 - $79.65 $717 - $796	10 Added 0.07%	14,548 $1.19 Million
Q3 2020 Oct 15, 2020	BUY	$73.18 - $82.95 $731 - $829	10 Added 0.07%	14,538 $1.21 Million
Q2 2020 Jul 17, 2020	BUY	$70.42 - $80.13 $704 - $801	10 Added 0.07%	14,528 $1.12 Million
Q1 2020 Apr 21, 2020	BUY	$63.36 - $87.82 $3,674 - $5,093	58 Added 0.4%	14,518 $1.12 Million
Q4 2019 Jan 28, 2020	SELL	$77.58 - $87.54 $17,765 - $20,046	-229 Reduced 1.56%	14,460 $1.32 Million
Q3 2019 Oct 25, 2019	SELL	$76.08 - $82.93 $22,215 - $24,215	-292 Reduced 1.95%	14,689 $1.24 Million
Q2 2019 Jul 26, 2019	SELL	$69.84 - $81.59 $163,495 - $191,002	-2,341 Reduced 13.51%	14,981 $1.26 Million
Q1 2019 Apr 16, 2019	SELL	$69.58 - $79.36 $84,818 - $96,739	-1,219 Reduced 6.57%	17,322 $1.44 Million
Q4 2018 Jan 29, 2019	SELL	$65.24 - $75.71 $32,098 - $37,249	-492 Reduced 2.58%	18,541 $1.42 Million
Q3 2018 Oct 24, 2018	BUY	$57.69 - $67.84 $576 - $678	10 Added 0.05%	19,033 $1.35 Million
Q2 2018 Jul 30, 2018	BUY	$50.83 - $59.72 $47,983 - $56,375	944 Added 5.22%	19,023 $1.16 Million
Q1 2018 Apr 18, 2018	BUY	$50.96 - $59.23 $21,403 - $24,876	420 Added 2.38%	18,079 $985,000
Q4 2017 Jan 26, 2018	SELL	$51.62 - $61.64 $1,187 - $1,417	-23 Reduced 0.13%	17,659 $994,000
Q3 2017 Oct 27, 2017	BUY	$58.67 - $63.13 $1.04 Million - $1.12 Million	17,682	17,682 $1.13 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Advisors Inc. with notifications on news.

Account

Cambridge Advisors Inc. Merck & Co., Inc. Transaction History